Literature DB >> 29168470

Seroepidemiology of parvovirus B19 among different age groups & pregnant women in India.

Rajlakshmi Viswanathan1, Babasaheb V Tandale2, Manisha S Tamayachekar1, Santoshkumar M Jadhav3, Kirtee A Khutwad1, Kiran R Munne1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 29168470      PMCID： PMC5719598          DOI： 10.4103/ijmr.IJMR_1847_15

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN： 0971-5916            Impact factor:   2.375


× No keyword cloud information.
  14 in total

1.  Age-related immunoglobulin G seroprevalence of human parvovirus B-19 in Israeli children.

Authors:  Dan Miron; Yoseph Horovitz; Anthony Luder; Frederic S Ohnona; Yechiel Schlesinger; Yechiel Schelisinger
Journal:  Isr Med Assoc J       Date:  2010-05       Impact factor: 0.892

2.  Adverse reproductive outcome induced by Parvovirus B19 and TORCH infections in women with high-risk pregnancy.

Authors:  Janak Kishore; Richa Misra; Abhiruchi Paisal; Yashodhra Pradeep
Journal:  J Infect Dev Ctries       Date:  2011-12-13       Impact factor: 0.968

3.  Seroprevalence of human parvovirus B19 in healthy blood donors.

Authors:  Satish Kumar; R M Gupta; Sourav Sen; R S Sarkar; J Philip; Atul Kotwal; S H Sumathi
Journal:  Med J Armed Forces India       Date:  2013-02-23

4.  The age-specific prevalence of human parvovirus immunity in Victoria, Australia compared with other parts of the world.

Authors:  H A Kelly; D Siebert; R Hammond; J Leydon; P Kiely; W Maskill
Journal:  Epidemiol Infect       Date:  2000-06       Impact factor: 2.451

5.  A pilot study on the seroprevalence of parvovirus B19 infection.

Authors:  Mary Abraham; Rajeev Rudraraju; Rajesh Kannangai; Koshy George; Thomas Cherian; Dolly Daniel; Sandeep Ramalingam; Gopalan Sridharan
Journal:  Indian J Med Res       Date:  2002-04       Impact factor: 2.375

6.  Seroepidemiology of pandemic influenza A (H1N1) 2009 virus infections in Pune, India.

Authors:  Babasaheb V Tandale; Shailesh D Pawar; Yogesh K Gurav; Mandeep S Chadha; Santosh S Koratkar; Vijay N Shelke; Akhilesh C Mishra
Journal:  BMC Infect Dis       Date:  2010-08-25       Impact factor: 3.090

7.  Standardization of B19 IgG ELISA to study the seroepidemiology of parvovirus B19 in North Indian voluntary blood donors.

Authors:  Janak Kishore; Manisha Srivastava; Nabjyoti Choudhary
Journal:  Asian J Transfus Sci       Date:  2010-07

Review 8.  Human parvovirus B19.

Authors:  Erik D Heegaard; Kevin E Brown
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

9.  Seroprevalence of parvovirus B19 in the German population.

Authors:  C Röhrer; B Gärtner; A Sauerbrei; S Böhm; B Hottenträger; U Raab; W Thierfelder; P Wutzler; S Modrow
Journal:  Epidemiol Infect       Date:  2008-01-16       Impact factor: 2.451

10.  Increased seroprevalence of IgG-class antibodies against cytomegalovirus, parvovirus B19, and varicella-zoster virus in women working in child day care.

Authors:  Gini G C van Rijckevorsel; Lian P M J Bovée; Marjolein Damen; Gerard J B Sonder; Maarten F Schim van der Loeff; Anneke van den Hoek
Journal:  BMC Public Health       Date:  2012-06-22       Impact factor: 3.295
View more
  1 in total

1.  Seroprevalences of antibodies against ToRCH infectious pathogens in women of childbearing age residing in Brazil, Mexico, Germany, Poland, Turkey and China.

Authors:  J M Warnecke; M Pollmann; V Borchardt-Lohölter; A Moreira-Soto; S Kaya; A G Sener; E Gómez-Guzmán; L Figueroa-Hernández; W Li; F Li; K Buska; K Zakaszewska; K Ziolkowska; J Janz; A Ott; T Scheper; W Meyer
Journal:  Epidemiol Infect       Date:  2020-10-30       Impact factor: 2.451
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.